loader
Asston Pharmaceuticals Limited
Issue Size (Net)
up to Rs.27.56 Cr
Price Band
Rs.123 per share
Issue Opens
July 09, 2025
Issue Closes
July 11, 2025
Company Highlights Financials Highlights Issue Details Prospectus

Company Highlights

1.Company Information

Incorporated in 2019, Asston Pharmaceuticals Limited is engaged in the business of pharmaceuticals, specializing in exporting healthcare products globally.
The company offers a diverse range of products, including tablets, capsules, sachets, and syrups. Its product portfolio encompasses various therapeutic categories, such as analgesics, antibiotics, antifungals, vitamins, and more.
The company manufactures pharmaceutical products for direct sales and also on a contract manufacturing or loan license basis, primarily working on a principle-to-principle approach with various marketers.

Asston Pharmaceuticals IPO Registrar
Maashitla Securities Private Limited

Phone: +91-11-45121795-96
Email:  ipo@maashitla.com
Website: https://maashitla.com/allotment-status/public-issues

Asston Pharmaceuticals Limited Financial Information (Restated)

Period Ended
Total Assets
Total Revenue
Profit After Tax
EBITDA
Net Worth
Reserves and Surplus
Total Borrowing
31-Mar-25
31.83
6.21
1.32
1.93
12.04
5.77
7.83
31-Mar-25
28.12
25.61
4.33
6.16
10.72
4.45
7.26
31-Mar-24
20.26
15.84
1.36
2.55
6.39
5.61
6.82
31-Mar-23
13.69
7.19
1.06
1.52
1.99
1.29
5.25
Amount in Rs. Crore

Asston Pharmaceuticals IPO Details

Issue Opening Date
July 09, 2025 
Issue Closing Date
July 11, 2025
Face Value
Rs.10 per share
Price
Rs.115 to Rs.123 per share
Lot Size
1,000 Shares
Sale Type
Fresh Capital
Issue Size
22,41,000 shares(aggregating up to Rs.27.56 Cr)
Reserved for Market Maker
1,13,000 shares (aggregating up to Rs.1.39 Cr)
Net Offered to Public
21,28,000 shares (aggregating up to Rs.26.17 Cr)
Issue Type
Bookbuilding IPO
Listing At
BSE SME

Asston Pharmaceuticals IPO Timeline (Tentative Schedule)

Event
Tentative Date
Opening Date
Wed, July 9, 2025
Closing Date
Fri, July 11, 2025
Tentative Allotment
Mon, July 14, 2025
Initiation of Refunds
Tue, July 15, 2025
Credit of Shares to Demat
Tue, July 15, 2025
Listing Date
Wed, July 16, 2025
Cut-off time for UPI mandate confirmation
5 PM on July 11, 2025

Prospectus

Prospectus File
Download

RR Investors Capital Services Pvt. Ltd AMFI-registered Mutual Fund Distributor

ARN-0032 Validity 14-Mar-2027

Head Office - 4th floor, Indraprakash Building 21, Barakhamba Road, New Delhi – 110001

callLandline Number
+91 11-4444-1111

Customer Care
+91 9350316010

Insight
Other Pages
RR Policies
Important Links
Security
  • SSL
Follow Us

SEBI Registration No: NSE Cash: INB231219636 | SEBI Registration No: NSE Derivative: INF231219636 | SEBI Registration No: BSE Cash: INB011219632 | SEBI Registration No: MCX-SX: INE261219636 | SEBI Registration No: NSE Currency: INE231219636 | SEBI Registration No: USE: INE271219631 | SEBI Registration No: CDSL: IN-DP-CDSL-3242005 | NCDEX Membership No: 00635 | MCX Membership No: 28850 | NSEL Membership No: 10650 | RBI Registration No: NBFC: N-14.03215 | IRDA Registration Number : CB-066/03 | AMFI Registration No : ARN -0032| SEBI Registration No: Merchant Banker: INM000007508

* Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.

© 2022 RR Investors Capital Services Pvt. Ltd | All Rights Reserved.